Completed
Topics
This public workshop enabled stakeholders to examine the current state of evidence for drug products used by pregnant and lactating persons, and discussed the barriers and opportunities for including these populations in clinical trials. It provided a foundation for a now completed consensus study on this topic, which was requested by Congress in the Consolidated Appropriations Act, 2022.
Featured publication
Inclusion of Pregnant and Lactating Persons in Clinical Trials: Proceedings of a Workshop
Proceedings
·2023
Approximately 4 million pregnant people in the United States give birth annually, and 70 percent of these individuals take at least one prescription medication during their pregnancy. Yet, due to a number of historical, ethical, legal, scientific, and societal issues, pregnant and lactating persons...
View details